Selected research
Industry Growth & Trends
Global Plasma for Fractionation Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Plasma for Fractionation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Plasma for Fractionation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Plasma for Fractionation is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Plasma for Fractionation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Plasma for Fractionation market include Biotest, BPL, CBPO, CSL, Grifols, Kedrion, LFB Group, Octapharma and Hualan Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Plasma for Fractionation market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Plasma for Fractionation market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Plasma for Fractionation market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Plasma for Fractionation.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Plasma for Fractionation market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Plasma for Fractionation Market by Company
Biotest
BPL
CBPO
CSL
Grifols
Kedrion
LFB Group
Octapharma
Hualan Bio
RAAS
Takeda
Plasma for Fractionation Segment by Type
Recovered Plasma
Source Plasma
Plasma for Fractionation Segment by Application
Albumin
Immune Globulin
Coagulation Factor
Others
Plasma for Fractionation Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma for Fractionation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma for Fractionation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma for Fractionation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Plasma for Fractionation companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Recovered Plasma
- Source Plasma
Applications
- Albumin
- Immune Globulin
- Coagulation Factor
- Others
Companies covered
- Biotest
- BPL
- CBPO
- CSL
- Grifols
- Kedrion
- LFB Group
- Octapharma
- Hualan Bio
- RAAS
- Takeda
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Plasma for Fractionation Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Plasma for Fractionation Market Size by Region (2021-2032)
- 1.4.1 Global Plasma for Fractionation Market Size by Region (2021-2026)
- 1.4.2 Global Plasma for Fractionation Market Size by Region (2027-2032)
- 1.5 Key Regions Plasma for Fractionation Market Size (2021-2032)
- 1.5.1 North America Plasma for Fractionation Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Plasma for Fractionation Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Plasma for Fractionation Market Size Growth Rate (2021-2032)
- 1.5.4 South America Plasma for Fractionation Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Plasma for Fractionation Market Size Growth Rate (2021-2032)
2 Plasma for Fractionation Market by Type
- 2.1 Type Introduction
- 2.1.1 Recovered Plasma
- 2.1.2 Source Plasma
- 2.2 Global Plasma for Fractionation Market Size by Type
- 2.2.1 Global Plasma for Fractionation Market Size Overview by Type (2021-2032)
- 2.2.2 Global Plasma for Fractionation Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Plasma for Fractionation Market Size Forecasted by Type (2027-2032)
- 2.3 Global Plasma for Fractionation Market Size by Regions
- 2.3.1 North America Plasma for Fractionation Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Plasma for Fractionation Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Plasma for Fractionation Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Plasma for Fractionation Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Plasma for Fractionation Market Size Breakdown by Type (2021-2026)
3 Plasma for Fractionation Market by Application
- 3.1 Type Introduction
- 3.1.1 Albumin
- 3.1.2 Immune Globulin
- 3.1.3 Coagulation Factor
- 3.1.4 Others
- 3.2 Global Plasma for Fractionation Market Size by Application
- 3.2.1 Global Plasma for Fractionation Market Size Overview by Application (2021-2032)
- 3.2.2 Global Plasma for Fractionation Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Plasma for Fractionation Market Size Forecasted by Application (2027-2032)
- 3.3 Global Plasma for Fractionation Market Size by Regions
- 3.3.1 North America Plasma for Fractionation Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Plasma for Fractionation Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Plasma for Fractionation Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Plasma for Fractionation Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Plasma for Fractionation Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Plasma for Fractionation Industry Trends
- 4.2 Plasma for Fractionation Industry Drivers
- 4.3 Plasma for Fractionation Industry Opportunities and Challenges
- 4.4 Plasma for Fractionation Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Plasma for Fractionation Revenue (2021-2026)
- 5.2 Global Plasma for Fractionation Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Plasma for Fractionation Key Company Headquarters & Area Served
- 5.4 Global Plasma for Fractionation Company, Product Type & Application
- 5.5 Global Plasma for Fractionation Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Plasma for Fractionation Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Plasma for Fractionation Players Market Share by Revenue in 2025
- 5.6.3 2025 Plasma for Fractionation Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Biotest
- 6.1.1 Biotest Company Information
- 6.1.2 Biotest Business Overview
- 6.1.3 Biotest Plasma for Fractionation Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Biotest Plasma for Fractionation Product Portfolio
- 6.1.5 Biotest Recent Developments
- 6.2 BPL
- 6.2.1 BPL Company Information
- 6.2.2 BPL Business Overview
- 6.2.3 BPL Plasma for Fractionation Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 BPL Plasma for Fractionation Product Portfolio
- 6.2.5 BPL Recent Developments
- 6.3 CBPO
- 6.3.1 CBPO Company Information
- 6.3.2 CBPO Business Overview
- 6.3.3 CBPO Plasma for Fractionation Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 CBPO Plasma for Fractionation Product Portfolio
- 6.3.5 CBPO Recent Developments
- 6.4 CSL
- 6.4.1 CSL Company Information
- 6.4.2 CSL Business Overview
- 6.4.3 CSL Plasma for Fractionation Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 CSL Plasma for Fractionation Product Portfolio
- 6.4.5 CSL Recent Developments
- 6.5 Grifols
- 6.5.1 Grifols Company Information
- 6.5.2 Grifols Business Overview
- 6.5.3 Grifols Plasma for Fractionation Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Grifols Plasma for Fractionation Product Portfolio
- 6.5.5 Grifols Recent Developments
- 6.6 Kedrion
- 6.6.1 Kedrion Company Information
- 6.6.2 Kedrion Business Overview
- 6.6.3 Kedrion Plasma for Fractionation Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Kedrion Plasma for Fractionation Product Portfolio
- 6.6.5 Kedrion Recent Developments
- 6.7 LFB Group
- 6.7.1 LFB Group Company Information
- 6.7.2 LFB Group Business Overview
- 6.7.3 LFB Group Plasma for Fractionation Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 LFB Group Plasma for Fractionation Product Portfolio
- 6.7.5 LFB Group Recent Developments
- 6.8 Octapharma
- 6.8.1 Octapharma Company Information
- 6.8.2 Octapharma Business Overview
- 6.8.3 Octapharma Plasma for Fractionation Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Octapharma Plasma for Fractionation Product Portfolio
- 6.8.5 Octapharma Recent Developments
- 6.9 Hualan Bio
- 6.9.1 Hualan Bio Company Information
- 6.9.2 Hualan Bio Business Overview
- 6.9.3 Hualan Bio Plasma for Fractionation Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Hualan Bio Plasma for Fractionation Product Portfolio
- 6.9.5 Hualan Bio Recent Developments
- 6.10 RAAS
- 6.10.1 RAAS Company Information
- 6.10.2 RAAS Business Overview
- 6.10.3 RAAS Plasma for Fractionation Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 RAAS Plasma for Fractionation Product Portfolio
- 6.10.5 RAAS Recent Developments
- 6.11 Takeda
- 6.11.1 Takeda Company Information
- 6.11.2 Takeda Business Overview
- 6.11.3 Takeda Plasma for Fractionation Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Takeda Plasma for Fractionation Product Portfolio
- 6.11.5 Takeda Recent Developments
7 North America
- 7.1 North America Plasma for Fractionation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Plasma for Fractionation Market Size by Country (2021-2026)
- 7.3 North America Plasma for Fractionation Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Plasma for Fractionation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Plasma for Fractionation Market Size by Country (2021-2026)
- 8.3 Europe Plasma for Fractionation Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Plasma for Fractionation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Plasma for Fractionation Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Plasma for Fractionation Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Plasma for Fractionation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Plasma for Fractionation Market Size by Country (2021-2026)
- 10.3 South America Plasma for Fractionation Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Plasma for Fractionation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Plasma for Fractionation Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Plasma for Fractionation Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst